HUMBERT H ET AL: "Human pharmacokinetics of dihydroergotamine administered by nasal spray.", CLINICAL PHARMACOLOGY AND THERAPEUTICS SEP 1996, vol. 60, no. 3, September 1996 (1996-09), pages 265-275, XP009168204, ISSN: 0009-9236 (B1)

LIPTON R B: "Ergotamine tartrate and dihydroergotamine mesylate: safety profiles.", HEADACHE 1997, vol. 37 Suppl 1, 1997, pages S33-S41, XP009168240, ISSN: 0017-8748 (B1)

MATHEW N T ED - WILEY-BLACKWELL PUBLISHING ET AL: "Dosing and administration of ergotamine tartrate and dihydroergotamine", HEADACHE, WOODBURY, NJ, UNITED STATES, vol. 37, no. suppl. 1, 1 January 1997 (1997-01-01), pages S26-S32, XP009167626, ISSN: 0017-8748 (B1)

SAPER JOEL R ET AL: "Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine.", HEADACHE NOV 2006, vol. 46 Suppl 4, November 2006 (2006-11), pages S171-S181, XP009168214, ISSN: 0017-8748 (B1)

WO-A-2005/025506 (B1)

SILBERSTEIN STEPHEN D ET AL: "Ergotamine and dihydroergotamine: history, pharmacology, and efficacy.", HEADACHE FEB 2003, vol. 43, no. 2, February 2003 (2003-02), pages 144-166, XP055056690, ISSN: 0017-8748 (B1)

US-A1- 2003 091 513 (B1)

WINNER P ET AL: "A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.", ARCHIVES OF NEUROLOGY FEB 1996, vol. 53, no. 2, February 1996 (1996-02), pages 180-184, XP009168208, ISSN: 0003-9942 (B1)

SCHRAN H F ET AL: "The pharmacokinetics and bioavailability of subcutaneously administered dihydroergotamine, heparin and the dihydroergotamine-heparin combination", THROMBOSIS RESEARCH, TARRYTOWN, NY, US, vol. 31, no. 1, 1 July 1983 (1983-07-01), pages 51-67, XP026443199, ISSN: 0049-3848 [retrieved on 1983-07-01] (B1)